Delivery Order SPE2DB22D1106-SPE2DB25FFEY6
- Not listed
- The Defense Logistics Agency awarded a $1,655.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml packaging under contract 4569133382. The award, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract is unset-aside and competitively awarded, with performance to occur at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18mL pack configuration, valued at $1,100.26 under a firm fixed-price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-competitive delivery order represents a purchase of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under...
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a contract ceiling value of $11,511.90. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,401.04, is for the supply of Provocholine Inhalation Solution, a medical product used in the diagnosis of respiratory disorders. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,026.79, is for the supply of Provocholine Inhalation Solution Packs (18 mL) to support military healthcare programs. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,650.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Provocholine inhalation solution, a medical product used in healthcare settings. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. AmerisourceBergen holds a...
- The Defense Logistics Agency awarded a $10,515.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Provocholine 100 mg vials. This non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Provocholine is a pharmaceutical product used in respiratory function testing and is part of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,501.30 firm fixed-price delivery order is for the supply of Provocholine Inhal Soln Pack 18ML, a medical product, with a performance period through April 1, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEY6Delivery Order
The Defense Logistics Agency awarded a $2,750.65 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Provocholine Inhalation Solution in 18 mL packs. This is a firm fixed-price contract with a completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Provocholine is a diagnostic agent commonly used in pulmonary function testing, and its procurement through this channel supports the Defense Health Agency and other federal healthcare systems' clinical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/25/25 |